Schizophrenic patients with polydipsia and water intoxication more often have a form of schizophrenia first described by Kraepelin

Psychiatry Research

Volumn 152, Issue 2-3, 2007, Pages 267-271

  Bralet, Marie Cecile ^a,b   Ton, T ^a,b   Falissard, Bruno ^b  

^a Clermont de l'Oise Mental Health Hospital   (France)

^b INSERM   (France)

Author keywords

Kraepelinian schizophrenia; Polydipsia and water intoxication; Severe form

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISORIENTATION; FAGERSTROM NICOTINE DEPENDENCE SCALE; FEMALE; HUMAN; MALE; NEGATIVE SYNDROME; POLYDIPSIA; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; WATER INTOXICATION;

DRINKING BEHAVIOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSYCHOANALYTIC THEORY; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; WATER INTOXICATION;

EID: 34547629257     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2006.11.009     Document Type: Article

References (61)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association Press, Washington, DC
2. Blum A., Tempey F.W., and Lynch W.J. Somatic findings in patients with psychogenic polydipsia. Journal of Clinical Psychiatry 44 (1983) 55-56
3. Bralet M.C., Yon V., Maréchal V., and Loas G. Clinical characteristics and risk factors for Kraepelinian subtype of schizophrenia: replication of previous findings and relation to summer birth. Psychiatry Research 111 (2002) 147-154
4. Bremmer A.J., and Regan A. Polydipsia and water intoxication in a mental handicap hospital. British Journal of Psychiatry 44 (1991) 55-56
5. Brownfield M.S., Greathouse J., Lorens S.A., Amstrong J., and Van de Kar J.H. Neuropharmacological characterization of serotoninergic stimulation on vasopressin secretion in conscious rats. Neuroendocrinology 47 4 (1988) 277-283
6. Buchsbaum M.S., Shihabuddin L., Hazlett E.A., Schröder J., Haznedar M.M., Powchik P., Spiegel-Cohen J., Wei T., Singer M.B., and Davis K.L. Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate. Schizophrenia Research 55 (2002) 25-40
7. Coward D.M., Imperato A., Urwyler S., and White T.G. Biochemical and behavioural properties of clozapine. Psychopharmacology 99 (1989) S6-S12
8. Crapanzano K.A., Casanova M.F., Toro V.E., and Gallagher B. Drinking behaviour as a result of a right hippocampal ictal focus. Biological Psychiatry 34 (1993) 889-892
9. De Leon J., Verghese C., Tracy J.L., Josiassen R.C., and Simpson G.M. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biological Psychiatry 35 (1994) 408-419
10. De Leon J., Tracy J., McCann E., and McGrory A. Polydipsia and schizophrenia in a psychiatric hospital: a replication study. Schizophrenia Research 57 (2002) 293-301
11. Delva N.J., and Crammer J.L. Polydipsia in chronic psychiatric patients: body weight and plasma sodium. British Journal of Psychiatry 152 (1988) 242-245
12. Emsley R., Roberts M., Smith R., Spangeberg J., and Chalton D. Disordered water homeostasis in schizophrenia and cerebral ventricular size. British Journal of Psychiatry 166 4 (1995) 501-506
13. Fitzsimons J.T., and Setler P.E. The relative importance of central nervous catecholaminergic and cholinergic mechanisms in drinking in response to angiotensins and other thirst stimuli. Biological Psychiatry 250 3 (1975) 613-631
14. Freestone S., McDonald T.M., Jeffrey R.F., Brown J., and Lee M.R. The renal effects of atrial natriuretic peptide in man are not attenuated by sulpiride. British Journal of Clinical Pharmacology 27 1 (1989) 13-18
15. Gupta S., and Baker P. Clozapine treatment of polydipsia. Annals of Clinical Psychiatry 6 2 (1994) 135-137
16. Hayashi T., Nishikawa T., Koga I., Uchida Y., Horiguchi J., and Yamawaki S. Implication of alpha 2 adrenergic system in polydipsia in schizophrenic patients. Psychopharmacology 130 (1997) 382-386
17. Hobson J.A., and English J.T. Self-induced water intoxication. Annals of Internal Medicine 58 (1963) 324-332
18. Holzbauer M., and Racke K. The dopaminergic innervation of the intermediate lobe and of the neural lobe of the pituitary gland. Medical Biology 63 3 (1985) 97-116
19. Hubbard J.L., Lin N., and Sibbad J.R. Subfornical organ lesions in rats abolish hyperdipsic effects of isoproterenol and serotonin. Brain Research Bulletin 23 1-2 (1989) 41-45
20. Illowsky B.P., and Kirch D.G. Polydipsia and hyponatremia in psychiatric patients. American Journal of Psychiatry 145 6 (1988) 675-683
21. Johnston C.I., Hodsman P.G., Kohzuki M., Casley D.J., Fabris B., and Phillips P.A. Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. American Journal of Medicine 26; 87 6B (1989) 24S-28S
22. Kay S.R., Lewis L.A., Opler J.P., and Lindenmayer. Reliability and validity of the Positive and Negative Syndrome Scale for Schizophrenics. Psychiatry Research 23 (1987) 99-110
23. Katafuchi J., Hattoi Y., Nagatomo I., and Koizumi K. Kappa-opioid antagonist strongly attenuates drinking of genetically polydipsic mice. Brain Research 12; 546 1 (1991) 1-7
24. Keefe R.S., Mohs R.C., Losonczy M.F., Davidson M., Silverman J.M., Kendler K.S., Horvath T.B., Nora R., and Davis K.L. Characteristics of very poor outcome schizophrenia. American Journal of Psychiatry 144 7 (1987) 889-895
25. Keefe R.S., Lobel D.S., Mohs R.C., Silverman J.M., Harvey P.D., Davidson M., Losonczy M.F., and Davis K.L. Diagnostic issues in chronic schizophrenia: Kraepelinian schizophrenia, undifferentiated schizophrenia and state independent negative symptoms. Schizophrenia Research 4 (1991) 71-79
26. Keefe R.S., Frescka F., Apter S.H., Davidson M., Maculoso J.M., Hirschowitz J., and Davis K.L. Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings. American Journal of Psychiatry 153 6 (1996) 806-811
27. Kenyon C.J., and Jardine A.J. Atrial natriuretic peptide: water and electrolyte homeostasis. Baillière's Clinical Endocrinology and Metabolism 3 2 (1989) 431-450
28. Kilzieh N., Wood A.E., Erdmann J., Raskind M., and Tapp A. Depression in Kraepelinian schizophrenia. Comprehensive Psychiatry 44 1 (2003) 1-6
29. Kirch D.G., Bigelow L.B., Weinberger D.R., Lawson W.B., and Wyatt R.J. Polydipsia and chronic hyponatremia in schizophrenic patients. Journal of Clinical Psychiatry 46 (1985) 179-181
30. Koczapski A.B., Ashby Y.T., Ibraheem S., Paredes J., Jones B.D., and Ancill R. Afternoon radiator-sitting syndrome: hypothermia and early diagnosis of self-induced water intoxication. British Journal of Psychiatry 151 (1987) 133-134
31. Lang R.E. Brain angiotensin. Handbook of Psychopharmacology vol. 161 (1983), Plenum Press, New York 307-361
32. Lawson W.B. Computer tomographic and endocrine findings in schizophrenic patients with hyponatremia. Biological Psychiatry 29 (1991) 86A (suppl)
33. Lee H.S., Kwon K.Y., Alphus L.D., and Meltzer L.H. Effect of clozapine on psychogenic polydipsia in chronic schizophrenia. Journal of Clinical Psychopharmacology 11 (1991) 222-223
34. Leibowitz S.F., Eidelman D., Suh J.S., Diaz S., and Sladek C.D. Mapping study of noradrenergic stimulation of vasopressin release. Experimental Neurology 110 3 (1990) 298-305
35. Loas G., Noisette C., Legrand A., and Delahousse J. A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS. Encéphale 23 1 (1997) 10-18
36. Luchins D.J. A possible role of hippocampal dysfunction in schizophrenic symptomatology. Biological Psychiatry 28 (1990) 87-91
37. Luchins D.J., Nettles K.W., and Goldman M.B. Anterior media temporal lobe volumes in polydipsic schizophrenic patients with and without hypoosmolemia: a pilot study. Biological Psychiatry 42 (1997) 767-770
38. Nishikawa T., Tsuda A., Tanaka M., Nishikawa M., Koga I., and Uchida Y. Naloxone attenuates drinking behaviour in a schizophrenic patient displaying self-induced water intoxication. Clinical Neuropharmacology 15 (1992) 310-314
39. Nishikawa T., Tsuda A., Tanaka M., Nishikawa M., Koga I., and Uchida Y. Naloxone attenuates drinking behaviour in a schizophrenic patient displaying self-induced water intoxication. Progress in Neuro-Psychopharmacology & Biological Psychiatry 18 (1994) 149-153
40. Nishikawa T., Tsuda A., Tanaka M., Nishikawa M., Koga I., and Uchida Y. Involvement of the endogenous opioid system in the drinking behaviour of schizophrenic patients displaying self-induced water intoxication: a double-blind controlled study with naloxone. Clinical Neuropharmacology 19 3 (1996) 252-258
41. Pavalonis D., Shutty M., Hundley P., Leadbetter R., Vieweg V., and Downs M. Behavioral intervention to reduce water intake in the syndrome of psychosis, intermittent hyponatremia and polydipsia. Journal of Behavior Therapy and Experimental Psychiatry 23 (1992) 51-57
42. Peterson D.T., and Marshall W.H. Polydipsia and inappropriate secretion of antidiuretic hormone associated with hydrocephalus. Annals of Internal Medicine 83 (1975) 675-676
43. Roy M.A., Merette C., and Maziade M. Subtyping schizophrenia according to outcome or severity: search for homogeneous subgroups. Schizophrenia Bulletin 27 1 (2001) 115-138
44. Samson W.K., Slaka K., Huang F.L., Ghuntz S., Alexander B., and Gomez-Sanchez C.E. Central nervous system action of endothelin-3 to inhibit water drinking in the rat. Brain Research 539 2 (1991) 347-351
45. Shutty Jr. M.S. Cigarette use, drinking and voiding in schizophrenic patients with polydipsia and hyponatremia. Schizophrenia Research 21 (1996) 195-197
46. Singh S., Padi M.H., Bullard H., and Freeman H. Water intoxication in psychiatric patient. British Journal of Psychiatry 146 (1985) 127-130
47. Sklar A.H., and Schrier R.W. Central nervous system mediators of vasopressin release. Physiological Reviews 63 (1983) 1243-1280
48. Smith W.O., and Clark M.L. Self-induced water intoxication in schizophrenic patients. American Journal of Psychiatry 137 (1980) 1055-1060
49. Snyder S.H. Drug and neurotransmitter receptors in the brain. Science 224 (1984) 22-31
50. Spigset O., and Hedenmalm K. Hyponatremia and the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) induced by psychotropic drugs. Drug Safety 12 3 (1995) 209-225
51. Suzuki M., Takeuchi O., Takegoshi I., and Kurachi K. Syndrome of inappropriate secretion of antidiuretic hormone associated with schizophrenia. Biological Psychiatry 31 (1992) 1057-1061
52. Tapp A., Tandon R., Scholten R., and Dudley E. Age disorientation in Kraepelinian schizophrenia: frequency and clinical correlates. Psychopathology 26 3-4 (1993) 225-228
53. Tracy J.L., Nematbakhsh M.A., de Leon J., McCann E.M., McGrory A., Quereshi G., and Josiassen R.C. A comparison of polydipsia prevalence among chronic psychiatric patients using three measurement approaches. Biological Psychiatry 42 (1997) 1097-1104
54. Umbricht D. Polydipsia and hippocampal pathology. Biological Psychiatry 36 10 (1994) 709-710
55. Unger T., Bles F., Ganten D., Lang R.E., Retting R., and Schwab N.A. Gabaergic stimulation inhibits central actions of angiotensin: II. Pressor responses, drinking and release of vasopressin. European Journal of Pharmacology 90 1 (1983) 1-9
56. Vieweg W.V., David J.J., Rowe W.T., Wampler G.J., Burns W.J., and Spradlin W.W. Death from self-induced water intoxication among patients with schizophrenic disorders. Journal of Nervous and Mental Disease 173 3 (1985) 161-165
57. Vieweg W.V., Hundley P.L., Godelski L.S., Tisdelle D.A., Pruzinsky T., and Yank G.R. Diurnal weight gain as a predictor of serum sodium concentration in patients with psychosis, intermittent hyponatremia and polydipsia (PIP syndrome). Psychiatry Research 26 (1988) 305-312
58. Vieweg W.V., Godleski L., and Hundley P.L. Antipsychotic drugs, lithium, carbamazepine and abnormal diurnal weight gain in psychosis. Neuropsychopharmacology 2 (1989) 39-43
59. Weinberger D.R., Berman K.F., and Zec R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. Archives of General Psychiatry 43 2 (1986) 114-124
60. Yamaguchi K., and Hama H. Facilitatory role of central dopamine in the osmotic release of vasopressin. Brain Research 481 2 (1989) 388-391
61. Zabik J.E., Sprague J.E., and Odio M. Interactive dopaminergic and noradrenergic systems in the regulation of thirst in the rat. Physiology & Behavior 54 1 (1993) 29-33